1. Home
  2. LFVN vs CABA Comparison

LFVN vs CABA Comparison

Compare LFVN & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFVN
  • CABA
  • Stock Information
  • Founded
  • LFVN N/A
  • CABA 2017
  • Country
  • LFVN United States
  • CABA United States
  • Employees
  • LFVN N/A
  • CABA N/A
  • Industry
  • LFVN Biotechnology: Pharmaceutical Preparations
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LFVN Health Care
  • CABA Health Care
  • Exchange
  • LFVN Nasdaq
  • CABA Nasdaq
  • Market Cap
  • LFVN 162.9M
  • CABA 149.3M
  • IPO Year
  • LFVN N/A
  • CABA 2019
  • Fundamental
  • Price
  • LFVN $13.08
  • CABA $1.62
  • Analyst Decision
  • LFVN Strong Buy
  • CABA Strong Buy
  • Analyst Count
  • LFVN 2
  • CABA 7
  • Target Price
  • LFVN $30.50
  • CABA $14.29
  • AVG Volume (30 Days)
  • LFVN 82.7K
  • CABA 1.3M
  • Earning Date
  • LFVN 09-04-2025
  • CABA 08-07-2025
  • Dividend Yield
  • LFVN 1.43%
  • CABA N/A
  • EPS Growth
  • LFVN 152.87
  • CABA N/A
  • EPS
  • LFVN 0.70
  • CABA N/A
  • Revenue
  • LFVN $222,347,000.00
  • CABA N/A
  • Revenue This Year
  • LFVN $17.36
  • CABA N/A
  • Revenue Next Year
  • LFVN $9.60
  • CABA N/A
  • P/E Ratio
  • LFVN $18.67
  • CABA N/A
  • Revenue Growth
  • LFVN 8.22
  • CABA N/A
  • 52 Week Low
  • LFVN $7.09
  • CABA $0.99
  • 52 Week High
  • LFVN $27.38
  • CABA $6.26
  • Technical
  • Relative Strength Index (RSI)
  • LFVN 48.87
  • CABA 51.47
  • Support Level
  • LFVN $12.07
  • CABA $1.54
  • Resistance Level
  • LFVN $14.08
  • CABA $1.83
  • Average True Range (ATR)
  • LFVN 0.70
  • CABA 0.13
  • MACD
  • LFVN -0.10
  • CABA 0.02
  • Stochastic Oscillator
  • LFVN 34.47
  • CABA 63.16

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: